ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,027Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1107

$1.24M Total Retail Price of All Prescriptions

Rank: 54 out of 1107

759 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 759 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

38% of this provider’s 759 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 18,729 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,945 1,264 S3 1 1
FUROSEMIDE 965 734 2 7
OMEPRAZOLE 721 555 3 4
LISINOPRIL 711 567 4 2
SIMVASTATIN 654 540 5 5
GABAPENTIN 622 390 6 9
LEVOTHYROXINE SODIUM 571 461 7 3
METFORMIN HCL 416 266 8 8
AMLODIPINE BESYLATE 392 278 9 6
METOPROLOL TARTRATE 384 305 10 10
POTASSIUM CHLORIDE 367 270 11 14
ATENOLOL 309 238 12 19
CARVEDILOL 302 250 13 27
CITALOPRAM HBR 281 195 14 17
WARFARIN SODIUM 278 220 15 15
RANITIDINE HCL 270 187 16 21
LANTUS 265 196 17 49
ISOSORBIDE MONONITRATE ER 264 206 18 34
AZITHROMYCIN 264 182 18 35
CLOTRIMAZOLE-BETAMETHASONE 264 211 18 198
TRAMADOL HCL 260 174 21 26
ZOLPIDEM TARTRATE 256 165 22 22
PROMETHAZINE HCL 256 135 R 22 44
SERTRALINE HCL 255 181 24 20
NEXIUM 231 161 25 18
TRAZODONE HCL 223 134 26 33
ALLOPURINOL 221 173 27 36
RISPERIDONE 205 190 28 79
THEOPHYLLINE ANHYDROUS 199 184 29 158
TRIAMTERENE-HCTZ 195 140 30 62
CLOPIDOGREL 190 110 31 28
HYDROCHLOROTHIAZIDE 182 131 32 11
LYRICA 180 58 33 83
MELOXICAM 175 165 34 25
JANUVIA 168 115 35 60
TIZANIDINE HCL 154 60 36 73
DIGOXIN 150 118 37 52
KLOR-CON 10 148 129 38 143
PROAIR HFA 148 67 38 37
DONEPEZIL HCL 147 142 40 32
ACETAMINOPHEN-CODEINE 145 78 S3 41 120
GLIPIZIDE 143 95 42 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 82 42 24
ATORVASTATIN CALCIUM 143 110 42 13
POLYETHYLENE GLYCOL 3350 141 100 45 46
IBUPROFEN 139 106 46 63
PRAVASTATIN SODIUM 138 71 47 12
PLAVIX 128 86 48 39
AMITRIPTYLINE HCL 128 96 R 48 48
NAMENDA 124 124 50 42
CRESTOR 121 66 51 23
METOPROLOL SUCCINATE 121 79 51 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 118 89 53 88
SUCRALFATE 117 72 54 121
INSULIN SYRINGE 115 92 55 78
TRAMADOL HCL-ACETAMINOPHEN 113 89 56 195
DIOVAN 112 94 57 51
GLIPIZIDE XL 110 91 58 166
SINGULAIR 107 77 59 65
DILTIAZEM 24HR CD 105 61 60 126
MIRTAZAPINE 104 62 61 61
TAMSULOSIN HCL 100 78 62 30
KLOR-CON M20 100 86 62 75
SODIUM CHLORIDE 99 93 64 186
VYTORIN 99 59 64 169
ENULOSE 97 67 66 399
AMOXICILLIN 95 61 67 90
PREDNISONE 95 81 67 40
FLUOXETINE HCL 95 33 67 47
LEVOFLOXACIN 94 72 70 71
NAPROXEN 93 57 71 80
FINASTERIDE 92 71 72 130
CLONIDINE HCL 87 47 73 53
LOVAZA 86 62 74 101
NOVOLOG 86 65 74 127
MECLIZINE HCL 85 84 76 114
GEMFIBROZIL 85 65 76 107
LOSARTAN POTASSIUM 83 45 78 29
SOTALOL 82 68 79 222
NOVOLIN R 81 72 80 187
ESCITALOPRAM OXALATE 81 65 80 82
ROPINIROLE HCL 81 63 80 69
SPIRIVA 80 60 83 57
PAROXETINE HCL 78 77 84 45
NYSTATIN 76 65 85 110
DIVALPROEX SODIUM 76 64 85 96
HYDRALAZINE HCL 74 64 87 99
METOCLOPRAMIDE HCL 74 38 87 116
ADVAIR DISKUS 73 47 89 54
OXYCODONE HCL-ACETAMINOPHEN 72 53 S2 90 93
LOSARTAN-HYDROCHLOROTHIAZIDE 72 56 90 66
FENTANYL 71 49 S2 92 105
PREMARIN 71 43 R 92 149
VENTOLIN HFA 69 68 94 97
EXFORGE 69 35 94 221
CIPROFLOXACIN HCL 68 45 96 59
KLOR-CON M10 66 65 97 159
MONTELUKAST SODIUM 66 46 97 118
ALENDRONATE SODIUM 63 50 99 41
COMBIVENT 63 47 99 112
ATENOLOL-CHLORTHALIDONE 63 59 99 189
PHENYTOIN SODIUM EXTENDED 61 61 102 147
QUETIAPINE FUMARATE 61 40 102 94
AMOX TR-POTASSIUM CLAVULANATE 61 40 102 131
GENERLAC 60 37 105 281
LEVETIRACETAM 58 19 106 141
CARBAMAZEPINE 56 0 107 215
BENZTROPINE MESYLATE 55 47 R 108 174
CYCLOBENZAPRINE HCL 54 34 R 109 56
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 109 77
CYMBALTA 53 19 111 50
OXYCODONE-ACETAMINOPHEN 53 28 S2 111 104
CEPHALEXIN 52 40 113 81
DOXEPIN HCL 51 41 114 180
DICYCLOMINE HCL 51 35 114 208
PANTOPRAZOLE SODIUM 50 39 116 30
KETOCONAZOLE 50 27 116 249
FLUTICASONE PROPIONATE 50 26 116 38
LACTULOSE 50 30 116 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.